Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection

NANot yet recruitingINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

July 31, 2027

Conditions
Prostate Cancer
Interventions
DEVICE

Promaxo portable MRI

"The Promaxo portable MRI is an FDA cleared MRI device for MR-guided procedures. It uses a novel truly open MRI with an unobstructed field of view and central aperture for robotic guided intervention and has a limited footprint allowing it to be places in a standard operating theatre or large clinic room. The strength of magnet is also low enough that special precautions and equipment are not to take biopsies."

Trial Locations (1)

W6 8RF

Imperial College London, London

All Listed Sponsors
lead

Imperial College London

OTHER